Home
AMARIN CORPORATION
Amarin's cardiovascular programs capitalize on Amarin's expertise in the field of lipid science and the known therapeutic benefits of essential fatty acids in treating cardiovascular disease.
AMR101 for Hypertriglyceridemia
AMR101 is prescription grade, ultra-pure (>96%) ethyl ester of eicosapentaenoic acid (ethyl-EPA; an omega-3 fatty acid). AMR101 is being positioned as a best-in-class prescription medicine for treating patients with high or very high triglycerides.
There is significant scientific and clinical evidence supporting the efficacy of ethyl-EPA in lowering triglyceride levels. AMR101 has been studied in over 1,000 patients in double-blind, placebo-controlled studies, including over 100 patients studied for greater than 12-months.
It is estimated that 40 million people in the US have elevated triglyceride levels, which are associated with the increased risk of developing coronary artery disease as well as being a component of certain other metabolic disorders, such as diabetes and obesity.

